During the 8-week treatment period the number ... twice a day for 8 weeks in patients with stable angina. New modified-release formulations of drugs represent a major advantage in the ...
Patients were allowed to take any other cardiovascular drug and any other agents for the treatment of concomitant diseases. Efficacy was assessed based on the mean number of angina attacks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results